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Brief Communication  
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Abstract 
Crouzon syndrome is a rare autosomal dominant premature cranyosynostosis, 
caused by fibroblast growth factor receptor 2 gene mutation on chromosome 10. 
The predominant skull and facial malformations with potential compromised 
airway make the crouzon syndrome a demanding issue for anesthesiologists and 
surgeons, required dynamic team work. In this report we describe a child, a 
known case of Crouzon syndrome who was a candidate for optic nerve 
decompression through endoscopic surgery. The anesthetic considerations and 
management are presented.  
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Rare genetic disorders are great challenges for 
anesthesiologists (1, 2). Crouzon syndrome is a rare, 
complex craniosynostosis of autosomal dominant 
transfer, with a highly variable phenotypic appearance 
and mutations in the fibroblast growth factor receptor 
2 (FGFR2) gene on chromosome 10 are known to 
cause it (3, 4). Due to a FGFR2 gene mutation, the 
disease is characterized by premature craniosynost-
osis, hypertelorism, orbital proptosis, psittichorhina 
(beaklike nose), hypoplastic maxilla and mandibular 
prognatism (5).  
Numerous findings from animal studies imply a 
critical role for FGFRs in the regulation of skeletal 
development (6). The majority of mutations in FGFR2 
are missense substitutions clustered around the third 
extracellular immunoglobulin-like domain, encoded 
by exons IIIa and IIIca (7). Most FGFR2 mutations 
affect the structure of the extracellular domain of the 
FGFR2 protein, are de novo when found in sporadic 
cases, segregate with the syndrome in familial cases, 
and are not found in the normal population (8). There 
are various kinds of mutations which have been studied 
with different phenotypes. A C342R mutation in 
FGFR2 with elbow deformity in Chinese patients (6), 
a firstly identified mutation s267p in FGFR2 (8), a 
novel sFGFR2-L617F mutation in tyrosine kinase 
domain related to premature suture closure (9) and  
mutations in the interleukin receptor IL-11RA cause of 
autosomal recessive Crouzon-like cranyosynostosis 
(10) are few examples of ongoing progression in 
figuring out this mysterious puzzle. 
Although there are different kinds of mutation 
with various expressivity, the same affected area in all 
types, the skull, is the major part that may need to 
undergo lots of therapeutic, corrective and cosmetic 
surgery thorough a patient’s life. Since these surgeries 
require multidisciplinary management, the 
anesthesiologist and the surgeons should be aware of 
and prepared for all difficulties may occur in 
perioperative period. 
Brief Report  
A 6 years old boy, known case of crouzon 
syndrome was admitted to our hospital due to acute 
deteriorating visual acuity, hydrocephaly and orbital 
mass. The nasal endoscopic surgery was scheduled for 
decompressing the optic nerve bilaterally. 
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He was an adopted child without any birth 
documents and family history. The caregivers did not 
have data about his milestones and the syndrome was 
diagnosed in pediatric ward based on clinical features 
of the disease. 
He had undergone three surgeries during his 
infancy and toddler years. The former was a shunt 
placement and the latter was medial and lateral 
tarsorrhaphy. The second surgery was a brain surgery 
without any documents.  
In preoperative assessment he was an alert child 
with stable vital signs and 21 kg weight. He had no 
limitation in physical activity and the mental 
development was acceptable for his age.  
In head and neck, the prominent forehead, 
hypertelorism, orbital proptosis, strabismus, low lying 
ears and micrognatia were conspicuous. There was no 
limitation in mouth opening and the mallampati score 
was II. In oral cavity inspection, there was an arched 
palate and some lost primary teeth. There was some 
limitation for neck extension. 
His visual exam demonstrated visual loss 
limited to perception of hand motion. The physical 
exam revealed no remarkable sign in cardiovascular 
and respiratory systems. The consultant neurosurgeon 
did not mention any problem like rising Intracranial 
pressure (ICP). 
In operation theatre the whole arsenal was 
prepared for compromised airway management, 
including different sizes of endotracheal tubes and 
laryngeal masks, stylete, bougie and quick track. The 
surgeon has been there already and prepared, in case of 
probable need for tracheotomy. 
Due to the certain concern about difficult 
intubation, the inhalation induction with sevoflurane 
with gradual rising percentage was chosen for the 
patient to maintain the spontaneous breathing. The 
depth of anesthesia has been assessed with Cerebral 
State Monitoring (CSM). The laryngoscopy was 
performed after the provider was assured about the 
enough depth of anesthesia through monitoring data. 
The Cormack score was 1 and the intubation with 
number 4 cuffed tube was done uneventfully. Fentanyl 
50 μg and atracurium 10 mg were given after securing 
the airway. While the bilateral sphenoidectomy, 
posterior and anterior etmoidectomy and bilateral optic 
nerve decompression was being performed, the child 
was on maintenance of 1.5 % Sevoflurane, 50% O2, 
50% N2O. Repeated doses of 5mg Atracurium and 25 
μg fentanyl were given during 255 minutes procedure. 
The hemodynamic indices, oxygen saturation and end 
tidal CO2 were in acceptable range. At the end the 
muscle relaxant was reversed with 1.5 mg Neostigmine 
and 0.5 mg Atropine. The child was extubated and 
 
Figure 1. Anterior view  
Figure 2. Lateral view 
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transferred to the recovery unit. After reaching full 
awake state and met the discharge criteria, he was 
transferred to a ward. 
Discussion 
Crouzon syndrome is a complex craniosynosto-
sis of autosomal dominant transfer, with a highly 
variable phenotypic appearance. Although of variable 
penetrance, is thought to be caused in part by a 
mutation in the fibroblast growth factor receptor-2 
(FGFR2) on chromosome 10q 25.3-q26 (4, 11) and  
more than 30 different mutations within the gene have 
been documented in separate families (11). Aside from 
craniofacial malformations, the disease can also cause 
hearing loss and airway challenges due to 
malformations in the nasal cavity and nasopharyngeal 
airway (4).  
Differential diagnosis of Crouzon’s syndrome 
are Apert syndrome and other problems including 
Carpenter syndrome, Pfeiffer syndrome, Seatre-
Chotzen syndrome, and Jackson Weiss syndrome (11). 
Before the novel achievements in mutation detection in 
genes, the diagnosis of Crouzon syndrome was made 
according to the clinical signs of the patients, including 
acrocephaly, exophthalmos and maxillary hypoplasia 
with ‘‘parrotbeak’’ nose, short upper lip, high narrow 
palate, narrowly spaced teeth and prognathism (7). 
Although the severity of these signs and symptoms 
varies among affected children (3), most of them need 
therapeutic, corrective and cosmetic surgeries from 
their infancy to older ages even adulthood including 
pregnancy (12). Craniofacial abnormalities are 
common at birth and may progress with time (3), thus 
anesthesiologists and surgeons are involved in 
challenging even  life threatening situations.  
From the perspective of an anesthesiologist, 
difficult intubation is the most important consideration 
in perioperative management in patients with 
abnormalities in head and neck and providing a secure 
airway in the same common surgical field is a 
demanding issue, required dynamic teamwork in the 
perioperative period. Even though the elective 
fiberoptic intubation is recommended in various 
literatures (12, 13) the device may not be available in 
the operating room, or the patient is uncooperative for 
the procedure. According to these issues, the 
anesthesiologists should be prepared and skilled 
enough in providing a secure airway with other 
alternative approaches. 
Our patient was uncooperative for awake 
elective fiberoptic intubation and he had a history of 
undergoing general anesthesia three times in the past 
without any documentation of the techniques and 
methods. We decided to provide general anesthesia 
with inhalation induction and maintain the 
spontaneous breathing. The surgery team was available 
in the operating room with all equipments in case of 
need to secure the airway through establishing 
emergency tracheostomy. Despite the fact that the 
operation lasted more than 4 hours, we did not face any 
untoward conditions in terms of bleeding, malposition, 
thermal and ventilation problems. 
Conclusion 
As a result of novel achievements in genetic and 
cellular studies and uprising hope to treat the patients 
with rare genetic disorders like Crouzon syndrome, 
anesthesiologists find themselves in new era required 
skillful adaptable individuals who can work in 
dynamic situations. The airway management, the most 
important breath taking issue in the perioperative 
period, requires full knowledge about the underlying 
disease, the perioperative probable events, the 
available equipment and making the best decision to 
use the least harmful technique 
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